Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Covetrus, Inc.
  6. News
  7. Summary
    CVET   US22304C1009

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Covetrus : Announces Second Quarter 2021 Earnings Release Date and Conference Call Information

07/29/2021 | 08:31am EDT

Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2021 results after the market closes on Thursday, August 5, 2021. Following the release, the Company will hold a conference call at 4:30 PM ET, during which Ben Wolin, president and chief executive officer, and Matthew Foulston, executive vice president and chief financial officer, will review the results.

To access the live webcast of the conference call and the corresponding slide presentation, individuals can register at our Investor Relations site: https://ir.covetrus.com/investors/events-and-presentations. An archived edition of the conference call will be posted at this link later that same day and will be available to interested parties for one year.

The conference call can also be accessed by dialing 866-789-2492 for U.S./Canada participants, or 409-937-8901 for international participants, and referencing confirmation code 5870228. A replay of the conference call will be available for two weeks through August 19, 2021 by dialing 855-859-2056 or 404-537-3406. The replay confirmation code is 5870228.

About Covetrus
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine with more than 5,500 employees serving over 100,000 customers around the globe. For more information about Covetrus visit https://covetrus.com/.


© Business Wire 2021
All news about COVETRUS, INC.
09/09VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
DJ
08/09COVETRUS : Barclays Adjusts Price Target on Covetrus to $38 From $46, Maintains ..
MT
08/05COVETRUS : Q2 Earnings Snapshot
AQ
08/05COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/05Covetrus Seeks Acquisitions
CI
08/05COVETRUS : Earnings Flash (CVET) COVETRUS Reports Q2 Revenue $1.19B, vs. Street ..
MT
08/05COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
08/05COVETRUS : Announces Financial Results for Second Quarter of 2021
BU
08/05COVETRUS : Issues Inaugural Environmental, Social and Governance (ESG) Report
BU
08/05Covetrus Reports Unaudited Consolidated Earnings Results for the Second Quart..
CI
More news
Analyst Recommendations on COVETRUS, INC.
More recommendations
Financials (USD)
Sales 2021 4 602 M - -
Net income 2021 -38,5 M - -
Net Debt 2021 758 M - -
P/E ratio 2021 -73,2x
Yield 2021 -
Capitalization 2 795 M 2 795 M -
EV / Sales 2021 0,77x
EV / Sales 2022 0,71x
Nbr of Employees 5 466
Free-Float 75,1%
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 20,26 $
Average target price 30,83 $
Spread / Average Target 52,2%
EPS Revisions
Managers and Directors
Benjamin C. Wolin President, Chief Executive Officer & Director
Matthew J. Foulston Chief Financial Officer & Executive Vice President
Philip A. Laskaway Chairman
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COVETRUS, INC.-29.51%2 788
ABBOTT LABORATORIES16.39%225 928
MEDTRONIC PLC11.76%176 193
BECTON, DICKINSON AND COMPANY4.98%75 436
HOYA CORPORATION30.10%63 907
ALIGN TECHNOLOGY, INC.36.29%57 543